Big Pharma has been able to afford to sell drugs abroad for less because of this reliance on their patents within the well-financed American market. Other countries have taken advantage of this by such maneuvers as threatening to duplicate the drugs themselves, effectively extorting pharma companies for lower prices. For decades the powerful Pharma lobby has been very successful at getting Washington to resist measures to provide relief from this lopsided and predatory situation.
But no longer, thanks to President Trump.
But no longer, thanks to President Trump.
No comments:
Post a Comment